- freely available
Protein Kinase C: An Attractive Target for Cancer Therapy
AbstractApoptosis plays an important role during all stages of carcinogenesis and the development of chemoresistance in tumor cells may be due to their selective defects in the intracellular signaling proteins, central to apoptotic pathways. Consequently, many studies have focused on rendering the chemotherapy more effective in order to prevent chemoresistance and pre-clinical and clinical data has suggested that protein kinase C (PKC) may represent an attractive target for cancer therapy. Therefore, a complete understanding of how PKC regulates apoptosis and chemoresistance may lead to obtaining a PKC-based therapy that is able to reduce drug dosages and to prevent the development of chemoresistance.
Share & Cite This Article
Marengo, B.; De Ciucis, C.; Ricciarelli, R.; Pronzato, M.A.; Marinari, U.M.; Domenicotti, C. Protein Kinase C: An Attractive Target for Cancer Therapy. Cancers 2011, 3, 531-567.View more citation formats
Marengo B, De Ciucis C, Ricciarelli R, Pronzato MA, Marinari UM, Domenicotti C. Protein Kinase C: An Attractive Target for Cancer Therapy. Cancers. 2011; 3(1):531-567.Chicago/Turabian Style
Marengo, Barbara; De Ciucis, Chiara; Ricciarelli, Roberta; Pronzato, Maria A.; Marinari, Umberto M.; Domenicotti, Cinzia. 2011. "Protein Kinase C: An Attractive Target for Cancer Therapy." Cancers 3, no. 1: 531-567.
Notes: Multiple requests from the same IP address are counted as one view.